Skip to content

Compared the effect of inferior pulmonary ligament for thoracoscopic upper lobectomy

A single-center prospective randomized controlled trial compared the effect of inferior pulmonary ligament for thoracoscopic upper lobectomy on surgical outcomes

Status
Unknown
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500109254
Enrollment
Unknown
Registered
2025-09-16
Start date
2025-06-20
Completion date
Unknown
Last updated
2025-09-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

completely loose group:The inferior pulmonary ligament is completely loose
partially loose group:The inferior pulmonary ligament is partially loose
Keep the lung ligament group:Keep the lung ligament

Sponsors

The First Affiliated Hospital of Nanchang University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Age >18 years old and <75 years old; 2. Patients who meet the indications for thoracoscopic left/right pulmonary lobectomy; 3. Preoperative cardiopulmonary function examination can tolerate patients with upper lung lobectomy; 4. Preoperative ECOG physical strength status score 0-1; 5. Preoperative ASA score I-II; 6. The patient or his authorized client is aware of the content and purpose of this study and agrees to;

Exclusion criteria

Exclusion criteria: 1. Patients with important organ dysfunction or other serious underlying diseases before the operation, with surgical contraindications and cannot tolerate surgery; 2. Patients who consider the presence of submediastinal lymph node enlargement and metastasis and need additional operation at the lower lung ligament; 3. Patients who have undergone thoracic surgery or radiofrequency ablation before; 4. Patients with concurrent pneumonia, empyema, tuberculous pleurisy, thoracic atresia, or conversion to open chest surgery were found during the operation; 5. Patients who are found to have malignant lung tumors in the middle and late stages, need medical treatment, and no surgical indications are required; 6. Patients with both lung lesions require surgery at the same time; 7. Patients or their authorized client refuse this researcher.

Design outcomes

Primary

MeasureTime frame
Postoperative residual cavity rate;Changes in bronchial angle after surgery;

Secondary

MeasureTime frame
The number of days and drainage of the thoracic drainage tube after surgery;

Countries

China

Contacts

Public ContactZeng Shanggan

The First Affiliated Hospital of Nanchang University

zengshanggan2009@163.com+86 791 88692525

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026